2020 Revenues ($USD) : $4,303,000,000
2020 R&D spend : not available
2020 Number of Employees : not available
Fiscal Year End : 12/31/2020
Key People : Robert Ford, CEO

Even after it spun off AbbVie at the start of 2013, Abbott kept an established pharmaceuticals business. Products in the business provide treatments in spaces including gastroenterology, women's health, cardiovascular, pain and central nervous system, and respiratory. Established pharmaceuticals make up more than 12% of Abbott's revenue. –CN